[Edaily Starin Choi Hee-jae Reporter] The movie "Insidious: They've Come Over" has raised anticipation by releasing footage that stirs up a sense of real-life horror. (Photo courtesy of Sony Pictures) “Insidious: They’ve Come Over” (Insidious) is a film depicting the brutal horror that unfolds as malevolent entities from “The Further”—the realm of the dead—search for a passage into the human world. The footage released on the 23rd begins with a scene of the protagonist, “Gemma” (Amelia Eve), at the dentist, foreshadowing the threat of unprecedented malevolent spirits infiltrating ordinary daily life. The unique point-of-view angle, starting from inside the patient’s mouth, transforms the familiar setting of a dental office into a place of terror, maximizing the tension. The scene where “Gemma,” examining the patient’s teeth and remarking, “It looks like something’s stuck here,” is suddenly engulfed by unexpected terror is both shocking and chilling. (Photo: Sony Pictures) Next, the “Red Door”—a central element of the *Insidious* universe—appears alongside the tagline “The Return of the Original Horror Series,” heightening anticipation, while a scene where an evil spirit threatens “Gemma’s” daughter “Maya” intensifies the sense of crisis. Additionally, the appearance of “Ellis” (Lynn Shaye), holding a lantern, foreshadows her upcoming role and piques curiosity. Accompanied by the tagline, “The true form of fear has finally crossed over into reality,” intense beings that traverse the boundary between “The Further” and the real world make their appearance, setting the stage for horror beyond imagination this summer. *Insidious* is a collaboration between the production team behind *The Backroom*—a film that garnered attention as a “new-style horror”—and horror master James Wan and Blumhouse. 'Insidious' is scheduled for theatrical release next month.
Fluctuations in credit spreads serve as an indicator of investor sentiment and capital flows in the corporate bond market. “Credit Signal” provides an intuitive analysis of the market’s overall trends…
Shinsegae Co.,Ltd Chairman Chung Yong-jin is returning to the forefront of management at E-MART Co., Ltd.(139480). Unlike in 2013, when he stepped down as a registered director and entrusted the busin…
“Batoclimab,” a treatment for autoimmune diseases developed by HANALL BIOPHARMA CO.,LTD(009420), has received new drug approval in China. This comes approximately nine years after the company licensed…